Overview
I help life science organizations navigate the complex transition from bench to bedside by aligning cutting-edge preclinical services with strategic commercial goals. With a PhD background and a track record of driving revenue growth in senior leadership roles across Europe and North America, I speak the language of both the lab and the boardroom. What I can offer: Technical Depth: Expert-level command of high-throughout screening approaches, ADME/DMPK, in vitro toxicology, and preclinical workflows. Commercial Execution: Proven success in consultative sales, sales management, contract nego [2]
Career history
- Chief Business OfficerJan 2025 to presentEDELRIS
- Founding Limited PartnerApr 2022 to presentPack Ventures
- Senior Manager, Global DMPK and in vitro ADME Business DevelopmentJul 2024 to Jan 2025Charles River Laboratories
- Global Late Discovery Specialist, Business DevelopmentOct 2023 to Jul 2024Charles River Laboratories
- Director, Global Pharmacology Client ServicesJan 2023 to Nov 2023Charles River Laboratories
- Global Director, Business Development (post-acquisition)Sep 2019 to Jan 2023SOLVO Biotechnology
- Vice President, Business Development (pre-acquisition)Sep 2016 to Sep 2019SOLVO Biotechnology
- Director, ADME-Tox ServicesJun 2015 to Sep 2016SOLVO Biotechnology
Education
- Ph.D., Biochemistry2003 - 2007Imperial College London
- M.Res., Integrative Biomedical Sciences2002 - 2003Imperial College London
- B.Sc. (Hons), Medical Molecular Biology1999 - 2002Cardiff University / Prifysgol Caerdydd
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.